# Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

> **NCT04202341** · — · RECRUITING · sponsor: **Alexion Pharmaceuticals, Inc.** · enrollment: 500 (estimated)

## Conditions studied

- Generalized Myasthenia Gravis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04202341
- **Lead sponsor:** Alexion Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-12-02
- **Primary completion:** 2029-10-01
- **Final completion:** 2029-10-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04202341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04202341, "Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04202341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*